XORTX Announces Positive Phase 2 Results in Type 2 Diabetic Nephropathy (T2DN)

    NEXT STORY
    PM360 Magazine Announces Winners of 2019 Trailblazer Awards
    PREV STORY
    Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Raptor Pharmaceutical to Participate in the 2016 JMP Life Sciences Conference

    NOVATO, Calif., June 14, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced ...

    author_avatar
    NASDAQ Market News

    Nanobiotix : Résultats Annuels 2018

    author_avatar
    NASDAQ Market News

    Pluristem to Present New Data from ARS study at Radiology Conference in U.S.

    HAIFA, Israel, June 29, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a ...

    author_avatar
    NASDAQ Market News